Peran Sekretori Imunoglobulin A dan Neutrofil pada Kejadian Early Onset-Ventilator Acquired Pneumonia Berdasarkan Analisis dari Spesimen yang Diambil dengan Kurasan Bronkoalveolar
105
BAB 7
DAFTAR PUSTAKA
Afessa, B., Hubmayr, R. D., Vetter, E. A., Keegan, M. T., Swanson, K. L.,
Baddour,L.M., Cockerill III,F.R., Peters,S.G. 2006. Bronchoscopy in
Ventilator-Associated Pneumonia: agreement of calibrated loop and serial
dilution. Am Respir Crit Care Med J. 173: pp 1229-1232.
Aghamohammadi, A., Moin, M., Farhoudi, A.,Rezaei, N., Pourpak, Z., Movahedi,
M., Gharagozlou, M., Nabavi, M., Shahrokhi, A. 2004. Efficacy of
intravenous immunoglobulin on the prevention of pneumonia in patients
with agammaglobulinemia. FEMS Immunol Med Microbiol J. 40:113-118.
Aguald-Ohman, C., 2007. Colonization, infection and dissemination in intensive
care patients. Department Intensive Care and clinical bacteriology,
Karolinska Institutet, Stochkhom, Sweden. 1st ed.
Ahl, J., Tham, J., Walder, M., Melander, E., Odenholt, I. 2010. Bacterial aetiology
in Ventilator-Associated Pneumonia at a Swedish University Hospital.
Scandinavian Infect Dis J. 42: 469-474.
American Thoracic Society Documents. 2005. Guidelines for the management of
adult with Hospital-Acquired, Ventilator-Associated and HealthcareAssociated Pneumonia. Am Respir Crit Care Med J. 171: 388-416.
Apostolopoulou, E., Charcharidou, M., Karga, A., Kaliakmanis. 2003. The
relationship of scoring systems and mortality in the intensive care unit.
Icus Nurs Web J.6: 1-8.
Augustyn, B. 2007. Ventilator–Associated Pneumonia: Risk Factors and
Prevention. Am Crit Care J. 27: 32-39.
Ballow, M. 2008. Immunoglobulin therapy methods of delivery. Allergy Clin
Immunol J. 122:1038-1039.
Bals, R., Hiemstra, P. S. 2004. Innate immunity in the lung : how epithelial cells
figh against respiratory pathogens. Eur Respir J. 23: 327-333.
105
106
Barreiro, B., Dorca, J., Manresa, F., Catalá, I., Esteban, L., Verdaguer, R.,
Gudiol, F. 1996. Protected Bronchoalveolar Lavage in the diagnosis of
Ventilator-Associated Pneumonia. Eur Respir J. 9: 1500-1507.
Baughman, R. P. 2007. Technical aspects of Bronchoalveolar Lavage:
Recommendations for a Standard Procedure. Semin Respir Crit Care
Med J. 28: 475-85.
Befus, A. D., Mowat, C., Gilchrist, C., Jing, H., Salomon, S., Baterman, A. 1999.
Neutrophil defences in induce histamine secreton from mast cells
mechanisms of action. Immunol J. 163: 947-953.
Bitonti, A. J., Dumount, J. A. 2006. Pulmonary administrations of therapeutic
proteins using an immunoglobulin transport pathway. Adv Drug Deliv Rev
J. 58:1106-1118.
Brandtzaeg, P. 1994. Human secretory immunoglobulin M. Immunol J. 29: 559565.
Budiarto, E. 2002. Biostatistika untuk kedokteran dan kesehatan masyarakat.
Jakarta: EGC.79-84
Boyton, R. J., Openshaw, P. J. 2002. Pulmonary defences to acute respiratory
infection. Br Med Bull J. 61:1-12.
Casetta, M., François, B., Antoun, S., Leclercq, B., Tancrède, C., Françoise, D.,
Nitenberg, G. 1999. Diagnosis of nosocomial pneumonia in cancer
patients undergoing mechanical ventilation a prospective comparison of
the plugged telescoping catheter with the protected specimen brush.
Chest J. 115: 1641-1645.
Chastre, J., Fagon, J. Y. 2002. Ventilator-Associated Pneumonia. Am Respir Crit
Care Med J. 165: 867-903.
Chawla, R. 2008. Epidemiology, etiology, and diagnosis of Hospital-Acquired
Pneumonia and Ventilator-Associated Pneumonia In Asian Countries . Am
Infect Control J. 36: 93-100.
107
Chung, D. R., Song, J-H., Kim, S. H., Thamlikitkul, V., Huang, S-G., Wang, H.,
So, T. M-k., Yasin, R. M. D., Hsueh, P-R., Carlos, C. C., Hsu, L. Y.,
Buntaran, L., Lalitha, M. K., Kim, M. J., Choi, J. Y., Kim, S. I., Ko, K. S.,
Kang, C-I., Peck, K. R. 2011. High prevalence of Multidrug-Resistant
Nonfermenters in Hospital-Acquired Pneumonia in Asia. Am Respir, Crit
Care Med J. 184 (12): 1409-17.
Clec’h, C., Jauréguy, F., Hamza, L., Karoubi, P., Fosse, J-P., Hamdi, A.,
Vincent, F., Gonzalez, F., Cohen, Y. 2006. Agreement between
quantitative cultures of postintubation tracheal aspiration and plugged
telescoping catheter, protected specimen brush, or BAL for the diagnosis
of nosocomial pneumonia. Chest J. 130: 956-961.
Cohen, A. L., Calfee, D., Fridkin, S. K., Huang, S. S., Jernigan, J. A., Lautenbach,
E., Oriola, S., Ramsey, K. M., Salgado, C. D., Weinstein, R. A. 2008.
Recommendations for metrics for Multidrug-Resistant Organisms in
healthcare settings: SHEA/HICPAC position paper. Infect Contr and Hosp
Epid J. 29: 901-13.
Cook, D. J., Walter, S.D ., Cook, R. J. 1998. Incidence of and Risk Factors for
Ventilator-Associated Pneumonia In Critically Ill Patients.
Ann Intern
Med J. 129:433-440.
Cordeiro, C. R., Cemlyn-Jones, J. 2008. Bronchoalveolar Lavage – Do We Need
It?. Professor and Resident Pulmonary Specialist Registrar, Department
of Pulmonology and Allergology, Coimbra University Hospital. Eur Respir
Dis J. 33-35.
Craven, D. E. 2006. 2005 Idsa/Ats Hospital-Acquired Pneumonia Guidelines: new
principles for improving management. Adv Stud Med J. 6(6C): S541S548.
Dahlan, M. D. 2013. Statistik untuk kedokteran dan kesehatan: deskriptif, bivariat,
dan multivariat, dilengkapi dengan menggunakan SPSS, edisi 5, cetakan
III. Jakarta: Penerbit Salemba Medika.
108
Danielle, R. P. 1999. Imunology sectretion in the airway. Annu Rev Physiol J. 52 :
177-195.
Dave, S., Carmicle, S., Hammerschmidt, S., Pangburn, M. K., McDaniel, L. S.
2004. Dual Roles of PspC, a Surface Protein of Streptococcus
pneumoniae, in Binding Human Secretory IgA and Factor H. Immunol J.
173: 471-477.
Delevaux, C., Roupie,Blot, E. F., Brochard, L., Lemaire, F., Brun-Buisson, C.
1997. Lower respiratory tract colonization and infection during severe
Acute Respiratory Distress Syndrome incidence and diagnosis. Am Respir
Crit Care Med J. 156:1092-1098.
Dennesen, P. J. W., Van Der Ven, A. J. A. M., Kessels, A. G. H., Ramsay, G.,
Bonten, M. J. M. 2001. Resolution of infectious parameters after
antimicrobial therapy in patients with Ventilator-associated Pneumonia.
Am Respir Crit Care Med J. 1371-1375.
Deša, K., Šustiæ, A., Krstuloviæ, B., Goluboviæ, V. 2005. Evaluation of single
intensive care unit performance by Simplified Acute Physiology Score II
system. Croat Med J. 46(6): 964-969.
Dey, A., Bairy, I. 2007. Incidence of Multidrug-Resistant Organisms causing
Ventilator-Associated Pneumonia in a tertiary care hospital: a nine
months' prospective study. Ann Thorac Med J. 2(2): 52-57.
Diebel, L. N., Liberati, D. M., Alfred, M. S., Baylor, E., Brown, W. J., Devlin, J.
2004. Immunoglobulin A protease is a virulence factor for gram-negative
pneumonia. Surg J .136: 937-943.
Diebel, L. N., Liberati, D. M., Baylor, A. E., Brown, W. J., Devlin, J. 2004.
Immunoglobulin A protease is a virulence factor for gram-negative
pneumonia. Surg J. 937-943.
Diebel, L. N., Liberati, D. M., White, M. T., Diglio, C. A., Brown, W. J. 2006.
A comparative study of secretory immunoglobulin A and immunoglobulin
G in host defense in an in vitro pneumonia model. Am Surg J. 191: 386390.
109
Diebel, L. N., Liberati, D., Amin, P. B., Diglio, C. A. 2009. Cleavage of sIgA by
gram negative respiratory pathogens enhance neutrophil inflammatory
potential. Trauma J. 66: 5;1336-1342.
Diebel, L. N., Liberati, D. M., Diglio, C. A. 2009. The relative roles of bacteria and
host inflammatory cells in sIgA degradation. Trauma J. 66:6;1556-1563.
Duflo,F., Debon,R., Monneret,G., Bienvenu,J., Chassard,D., Allaouchiche,B.,
2002. Diagnostic and Prognostic Value in Ventilator-associated
Pneumonia. Anest J. 96: 74-79.
Elatrous, S., Boukef , R., Besbes, L. O., Marghli, S., Nooman, S., Nouira, S.,
Abroug, F. 2004. Diagnosis of Ventilator-Associated Pneumonia:
agreement between quantitative cultures of endotracheal aspiration and
plugged telescoping catheter. Intensiv Care Med J. 30: 853-858.
Elgert, K. D. 2009. Immunology, Understanding The Immun System. 2nd, Hoboken
Inc. New Jersey. 9-32
El-Herte,R.S., Kanj,S.S., Matar,S.G.M., Araj,G.F. 2012. The
Threat of
Carbapenem-Resistant Enterobacteriaceae In Lebanon: An update on
the regional and local epidemiology. Infect and Pub Health J. 5: 233243.
Erbay, R. H., Yalcin, A. N., Zencir, M., Serin, S., Atalay, H. 2004. Research article
costs and risk factors for Ventilator-Associated Pneumonia In a Turkish
University Hospital's Intensive Care Unit: A case-control study. BMC
Pulmo Med J. 4:3;1-7.
Erle, D. J., Zhen, G. 2006. Microbiological Diagnosis of Ventilator-associated
Pneumonia: Using the Data to Optimize Clinical Outcomes. Am J Respir
Crit Care Med J. 173: 1182-1184.
Fagon, J-Y., Chastre, J. 2003. Diagnosis and treatment of nosocomial pneumonia
in ALI/ARDS patients. Eur Respir J. 22: Suppl. 42, 77s-83s.
110
Fagon, J-Y., Chastre, J., Rouby, J-J. 2007. Is Bronchoalveolar Lavage with
quantitative cultures a useful tool for diagnosing Ventilator-Associated
Pneumonia?. Crit Care J. 11: 123-125.
Fartoukh, M., Maître, B., Honore, S., Cerf, C., Zahar, J-R., Brun-Buisson, C.
2003. Diagnosing pneumonia during mechanical ventilation: The Clinical
Pulmonary Infection Score revisited. Am Respir Crit Care Med J. 168:
173-179.
Ferrer, M., Liapikou, A., Martinez, J. A., Mensa, J., Valencia, M., Torres, A.,
Esperatti, M., Theessen, A. 2010. Validation of the American Thoracic
Society–Infectious Diseases Society of America Guidelines for HospitalAcquired Pneumonia in the Intensive Care Unit. Clin Infect Dis J. 50: 945952.
File, T. M. 2010. Recommendations for treatment of Hospital Acquired and
Ventilator-Associated Pneumonia: review of recent International
guidelines. Infect Dis Soc Am J. S42-S47.
Furst, D, E. 2008. serum immunoglobulins and risk of infection: how low can you
go?. Semin Arth Rheum J. 39:18-29.
George, D. L. 1995. Epidemiology of Nosocomial Pneumonia in Intensive Care
Unit Patients. Clin Chest Med J. 16:1; 29-44.
Giantsou, E., Liratzopoulos, N., Efraimidou, E., Panopoulou, M., Alepopoulou, M.
E., Kartali-Ktenidou, S., Minopoulos, G. I., Zakynthinos, S., Manolas, K. I.
2005. Both Early-onset and Late-onset Ventilator-Associated Pneumonia
Are Caused Mainly by Potentially Multiresistant Bacteria. Intensiv Care
Med J. 31:1488-1494.
Grigoriu, B., Jacobs, F., Beuzen, F. 2005. Bronchoalveolar lavage cytological
alveolar damage in patients with severe pneumonia. BMC Pulmo Med J.
6: 10-16.
Gorman, S. K., Stewart, L. M., Slavix, R. S., Lemos, J., Chittock, D. 2009.
Identifying missed opportunities to curtail antimicrobial therapy for
111
presumed Ventilator-Associated Pneumonia using the Clinical Pulmonary
Infection Score. Can Hosp Pharm J. 62: 3; 217-225.
Gottesman, S. R. S., Strober, W. 2009. Immunology, Clinical Case Studies and
Diseases Pathophysiology. Hoboken Inc, New Jersey.
Guler, E., Kahveci, F., Akalin, H., Sinirtas, M., Bayram, S., Ozcan, B. 2012.
Evaluation of A Clinical Pulmonary Infection Score In The Diagnosis of
Ventilator-Associated Pneumonia. Signa Vitae J. 7(1): 32-37.
Hajishengallis, G., Nikolova, E., Russell, M. W. 1992. Inhibition of streptococcus
mutans adherence to saliva-coated hydroxyapatite by human secretory
immunoglobulin A (S-IgA) antibodies to cell surface protein antigen 1/11:
reversal by iga1 protease cleavage. Infect Immun J. 60:2; 5057-5064.
Halbertsma, F. J. J., Vaneker, M., Scheffer, G. C., Van Der Hoeven, J.G. 2005.
Cytokines and biotrauma in Ventilator Induced Lung Injury: a critical
review of the literature. Med J. 63;10:382-392.
Hamilton,L.A., Wood,G.C., Magnotti,L.J., Croce,M.A., Martin,J.B., Swanson,J.M.,
Boucher,B.A., Fabian,T.C. 2012.
Treatment of Methicillin-Resistant
Staphylococcus aureus Ventilator-Associated Pneumonia With HighDose Vancomycin or Linezolid. Trauma Acute Care Surg J. 72(6):
1478-1483.
Harde, Y., Rao, S. M., Sahoo, J., Bharuka, A., Swetha, B., Saritha, P. 2013.
Detection Of Ventilator Associated Pneumonia, using Clinical Pulmonary
Infection Score (CPIS) In critically ill neurological patients. Anest Clin
Scien J. 2: 20-22.
Haslam, P. L., Baugham, R. P. 1999. Report of ERS task force: guidelines for
measurement of a cellular components and standardization of BAL. Eur
Respir J.14: 245-248.
Horan, T. C., Andrus, D. M. A. 2008. CDC/NHSN Surveillance definition of Health
Care–Associated Infection and criteria for specific types of infections in
the acute care setting. Am Infect Contr J. 36: 309-332.
112
Huang, K-T., Tseng, C- C., Fang, W-F., Lin, M-C. 2010. An Early predictor of
The outcome of Patients with Ventilator-associated Pneumonia. Chang
Gung Med J. 33: 274-282.
Hunter, J. D. 2006. Ventilator- Associated Pneumonia. Postgrad Med J. 82:172178.
Ibrahim,E.H., Ward,S., Sherman,G., Kollef,M.H. 2000. A Comparative Analysis
of Patients With Early-Onset vs Late-Onset Nosocomial Pneumonia in
the ICU Setting. Chest J. 117:1434-1442.
Inglis, T. J., Millar, M. R., Jones, G., Robinson, D. 1989. Tracheal tube biofilm as
a source of bacterial colonization of the lung. Clin Microbiol J. 2014-2018.
Ioanas, M., Ferrer, R., Angrill, J., Ferrer, M., Torres, A. 2001. Microbial
investigation in Ventilator-associated Pneumonia. Eur Respir J. 17: 791801.
Jiménez, P., Saldías, F., Meneses, M., Silva, M. E., Wison, M. G., Otth, L. 1993.
Diagnostic fiberoptic bronchoscopy in patients with Community-acquired
Pneumonia: Comparison Between Bronchoalveoar Lavage and
telescoping plugged catheter cultures. Chest J. 103: 1023-1027.
Jeon,E.J., Jung,J.W., Choi,J.C., Shin,J.W., Park,I.W., Choi,B.W., Park,A.J.,
Kim,J.Y. 2010. The Value of Procalcitonin and the SAPS II and
APACHE III Scores in the Differentiation of Infectious and Noninfectious Fever in the ICU: A Prospective, Cohort Study. Korean Med
Sci J. 25(11): 1633-1637.
Jones, R. N. 2010. Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia
and Ventilator-Associated Bacterial Pneumonia. Clin Microbiol Rev J. 51:
S81-S87.
Joseph, N. M., Sistla, S., Dutta, T. K., Badhe, A. S., Parija, S. C. 2010. VentilatorAssociated Pneumonia: Role Of Colonizers And Value Of Routine
Endotracheal Aspirate Cultures. Inter Infect Dis J. 14: e723-e729.
113
Kayacan, O., Beder, S., Karnak, D. 2003. Cellular profile of Bronchoalveolar
Lavage fluid in Turkish Miners. Postgrad Med J. 79: 527–530.
Klompas, M., Kulldorff, M., Platt, R. 2008. Risk of misleading VentilatorAssociated Pneumonia rates with use of standard clinical and
microbiological criteria. Clin Infect Dis J. 46: 1443–6.
Klompas, M., Yokoe, D. S. 2009. Automated Surveillance of Health Care–
Associated Infections. CID Healthcare Epid J. 48: 1268-1275.
Koenig, S. M., Truwit, J. D. 2006. Ventilator-Associated Pneumonia: Diagnosis,
Treatment, and Prevention. Clin Microbiol Rev J. 637-657.
Koerner, R. J. 2004. Contribution of endotracheal tubes to the pathogenesis of
Ventilator-Associated Pneumonia. Hosp Infect J. 35: 83-89.
Kollef, M. H. 2006. Microbiological diagnosis of Ventilator-Associated Pneumonia.
Am Respir Crit Care Med J. 173: 2006-2007.
Lamm, M. E. 2006. How epithelial transport of IgA antibodies relates to host
defense. Am Phisiol Gastrointest J. 274: 614-617.
Laursen, A. L., Jensen, B. N., Andersen, P. L. 1994. Local antibodies against
pneumocystis carinii in bronchoalveolar lavage Fluid. Eur Respir J. 7: 679685.
Le-Gall, J-R., Neumann, A., Hemery, F., Bleriot, J. P., Fulgencio, J. P., Garrigues,
B., Gouzes, C., Lepage, E., Moine, P., Villers, D. 2005. Mortality
prodiction using SAPS II: an update for french intensive care unit. Crit
Care J. 9: 645-652.
Lee, W. L., Downey, G. P. 2001. Neutrophil activation and Acute Lung Injury. Cur
Opinion in Crit Care J. 7: 1-7.
Leo, A., Galindo-Galindo, J., Folch, E., Guerrero, A., Arroliga, A. C., Bosques, F.,
Mercado, R. 2008. Comparison Of Bronchoscopic Bronchoalveolar
Lavage Vs Blind Lavage with a modified nasogastric tube in the etiologic
diagnosis of Ventilator-Associated Pneumonia. Med Intensiv J. 32(3): 115120.
114
Levin, A. S., Oliveira, M. S. 2008. The challenge of Multidrug Resistance: the
treatment of gram-negative rod infections. Shock J. 30: S1: 30-33.
Linssen, C. F.M. 2007. Diagnostic Value of Bronchoalveolar Lavage in Infectious
Disorders. Datawyse Universitaire Pers Maastracht.1st ed
Liu,K-S., Wang,Y-T., Lai,Y-C., Yu,S-F., Huang,S-J., Lu,H-J.M-C., Hsueh,P-R.
2011. Antimicrobial resistance of bacterial isolates from respiratory care
wards in Taiwan: a horizontal surveillance study comparison of the
characteristics of nosocomial infection and antimicrobial-resistant bacteria
in adult Intensive Care Units and two respiratory care facilities for
mechanically ventilated patients at a tertiary care centre in Taiwan. Intern
Antimicrobial Agents J. 37: 10-5.
Luna, C. M., Aruj, P., Niederman, G. J., Violi, D., Prignoni, A., Rίos, F., Baquero,
S., Gando, S. 2006. Appropriateness and Delay to Initiate Therapy in
Ventilator-Associated Pneumonia. Eur Respir J. 27: 158-64.
Lusuardi, M., Capelli, A., Stefano, A. F., Donner, C. F. 2002. Lung mucosal
immunity: immunoglobulin - A Revised. Eur Respir J. 19: 785-786.
Mai, M-H., Tsai, H-C., Lee, Z. S-J., Wang, Y-H., Chen, Y-S., Wann, S-R., Liu, YC. 2007. Multidrug-Resistant Acinetobacter baumannii In VentilatorAssociated Pneumonia at a medical center in Southern Taiwan. Microbiol
Immunol Infect J. 40: 401-405.
Mara, A. R., Cal, R. G. R., Silva, C. V., Caserta, R. A., Paes, Â. T., Moura, D. F.,
Santos, F. P., Edmond, M. B., Durão, M. S. 2009. Succesful prevention of
Ventilator-associated Pneumonia in an intensive care setting. Am Infect J.
37: 619-625.
Martin, T. R., Frevert, C. W. 2005. Innate immunity in the lungs. Proc Am Thorac
Sov J. 2: 403-411.
McGowan Jr, J. E. 2006. Resistance in Nonfermenting Gram-Negative Bacteria:
Multidrug Resistance to The Maximum. Am Infect Control J. 34: S29-S37.
Mayer, L., 2003. Mucosal immunity. Ped J. 111: 1595-1600.
115
Medford, A. R. L., Husain, S. A., Turki, H. M., Millar, A. B., 2009. Diagnosis of
Ventilator-Associated Pneumonia. Crit Care J. 24: 473.1-6.
Medzhitov, R. 2008. Origin and physiological roles of inflammation. Nature J.
454: 428-436.
Mestecky, J. 2005. Mucosal immunology 3rd ed. Academic press, San Diego.
72-79.
Meyer, K. C., Raghu, G., Baughman, R. P., Brown, K. K., Costabel, U., Bois, R.
M., Drent, M., Haslam, P. L., Kim, D. S., Nagai, S., Rottoli, P., Saltini, C.,
Selman, M., Strange, C., Wood, B., and the American Thoracic Society
Committee on BAL in Interstitial Lung Disease. 2012. Guideline: The
clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung
disease. Am Respir Crit Care Med J. 185: 9; 1004-1014.
Meyer, K. C. 2012. The value of Bronchoalveolar Lavage In the diagnosis and
management of Interstitial Lung Disease. Chest J. 271-293.
Mietto, C., Pinciroli, R., Patel, N., Berra, L. 2013. Ventilator Associated
Pneumonia: evolving definitions and preventive strategies. Respir Care
J.13:256-9.
Milbrandt, E. B., Ishizaka, A., Angus, D. C. 2006. Update in Critical Care 2005.
Am Respir Crit Care Med J. 173: 833-841.
Mimoz, O., Karim, J., Mazoit, J. X., Edouard, A., Leprince, S., Nordmann, P.
2000. Gram Staining of Protected Pulmonary, Specimens in The Early
Diagnosis of Ventilator-Associated Pneumonia. Br Anaesth J. 85: 735739.
Morrison, D., Strieter, R. M., Donnelly, S. C., Burdick, M. D. 1998. Neutrophil
Chemokines in Bronchoalveolar Lavage Fluid and Leukocyte-Conditioned
Medium From Nonsmokers and Smokers.Eur Respire J. 998: 12; 10671072.
Müller, B., Harbarth, S., Stolz, D., Bingisser, R., Mueller, C., Leuppi, J.,
Nusbaumer, C., Tamm, M., Christ-Crain, M. 2007. Diagnostic and
116
prognostic accuracy of clinical and laboratory parameters in communityacquired pneumonia. BMC Infect Dis J. 7:10-12.
Munro, C. L., Grap, M. J. 2004. Oral health and care in the intensive care unit:
state of the science. Am Crit Care J.13: 25-34.
Muòz, A. R., 2005. Mucosal immunity in the respiratory tract: the role of IgA in
protection against intracellular pathogens. Doctoral thesis from the
department of immunology, The Wenner-Gren Institute, Stockholm
University. Stockholm.
Nicasio, A. M., Eagye, K. J., Nicolau, D. P., Shore, E., Palter, M., Pepe, J., Kuti,
J. L. 2010. Pharmacodynamic-based clinical pathway for empiric antibiotic
choice in patients with Ventilator-associated Pneumonia. Crit Care J. 25:
69-77.
Niederman, M. S. 2005. The Clinical Diagnosis of Ventilator-Associated
Pneumonia. Respir Care J. 50(6): 788-796.
Noble, P. W., Jiang, D. 2006. Matrix regulation of lung injury, inflammation and
repair. the role of innate immunity.Proc Am Thorac Soc J. 3: 401-404.
Ntoumenopoulos,G., Presneill,J.J., McElholum,M., Cade,J.F. 2002.Chest
physiotherapy for the prevention of Ventilator-Associated Pneumonia.
Intensiv Care Med J. 28: 850-856.
Oeckler, R. A., Hubmayr, R. D. 2007. Ventilator-associated Lung Injury: a search
for better therapeutic targets. Eur Respir J. 30: 1216-1226.
Parks, N. A., Magnotti, L. J., Weinberg, J. A., Zarzaur, B. L., Schroeppel, T. J.,
Swanson, J. M., Fabian, T. C., Croce, M. A. 2012. Use of The Clinical
Pulmonary Infection Score To Guide Therapy For Ventilator-Associated
Pneumonia Risks Antibiotic Over exposure In Patients With Trauma.
Trauma Acute Care Surg J. 52-59.
Prakash, P., Krishna, K., Bhatia, D. 2006. Usefulness of SAPS II Scoring system
as an early predictor of outcome in ICU patients. JIACM J.7(3): 202-205.
117
Pugin, J., Auckenthaler, R., Mill, N., Janssens, J-P., Lew, P. D., Suter, P. M.
1991. Diagnosis of Ventilator-associated Pneumonia by Bacteriologic:
Analysis of Bronchoscopic and Nonbronchoscopic "Blind"
Bronchoalveolar Lavage Fluid. Am Rev Respir Dis J. 143: 1121-1129.
Ramirez, P., Valencia, M., Torres, A. 2007. Bronchoalveolar Lavage to diagnose
respiratory infections. Semin Respir Crit Care Med J. 28: 525-533.
Ranes, J. L., Gordon, S., Arroliga, A. C. 2005. Hospital-Acquired, Health Care–
Associated, and Ventilator-Associated Pneumonia. Cleveland Clinic.
1.1.1.1 Rasmin, M., 2012. Bronchoalveolar Lavage pada interstitial lung
disease, Departemen Pulmonologi dan Ilmu Kedokteran Respirasi FKUI –
SMF Paru RSUP Persahabatan, Jakarta
Rello, J., Gallego, M., Mariscal, D., Soñora, R., Valles, J. 1997. The value of
routine microbial investigation in Ventilator-Associated Pneumonia. Am
Respir Crit Care Med J. 156:196-200.
Rello, J., Sa-Borges, M., Correa, H., Leal, S-R., Baraibar, J. 1999. Variations in
etiology of Ventilator-associated Pneumonia across four treatment sites:
implications for antimicrobial prescribing practices. Am Respir Crit Care
Med J. 160: 608-613.
Rea-Neto, A., Youssef, N. C. M., Tuche, F., Brunkhorst, F., Raniere, V. M.,
Reinhart, K. 2008. Diagnosis of Ventilator-Associated Pneumonia: a
systemic review of the literature. Crit Care J. 12: 56-70.
Renegar, K. B., Small, P. A., Boykins, J. L. G., Wright, P. F. 2004. Role of IgA
versus IgG in the control of influenza viral infection in the murine
respiratory tract. Immunol J.173: 1978-1986.
Reutershan, J., Ley, K., 2004. Bench-to-bedside review: Acute Respiratory
Distress Syndrome-how neutrophils migrate into the lung. Crit Care J. 8:
453-461.
Roon, A. H. R., Bonten, M. J. M., Gaillard, A. C. 1998. Prediction of clinical
severity and outcome of Ventilator-associated Pneumonia, comparison of
118
Simplified Acute Physiology Score with systemic inflammatory mediators.
Am Respir Crit Care Med J.158: 1026-1031.
Rotstein, C., Evans, G., Born, A., Grossman, A., Light, R. B., Magder, S.,
Taggart, B., Weiss, K., Zhanel, G. G. 2008. Ammi Canada Guidelines:
clinical practice guidelines for Hospital-Acquired Pneumonia and
Ventilator -Associated Pneumonia in adults. Can Infect Dis Med Microbiol
J. 19: 19-53
Safdar, N., Crnich, C. J., Maki, J. G., 2005. The Pathogenesis of VentilatorAssociated Pneumonia: Its Relevance to Developing Effective Strategies
for Prevention. Respir Care J. 50: 6; 725-742.
Santoso, Singgih. 2012. Aplikasi SPSS pada statistik multivariat. Jakarta: PT Elex
Media Komputindo. 11-85.
Satcher, D. 1997. Centers for disease control and prevention. Guidelines for
prevention of nosocomial pneumonia. MMWR J. 46: 1-67.
Schmekel, B., Venge, P., Hörnblad, Y., Norlund, A. L., Hvatum, M. 1995. Kinetic
retrieval of eosinophil cationic protein, hyaluronan, secretory IgA, albumin,
and urea during BAL in healthy subjects. Chest J. 108: 62-67.
Shan, J., Chen, H-L., Zhu, J-H. 2011. Diagnostic accuracy of Clinical Pulmonary
Infection Score for Ventilator-Associated Pneumonia: a meta-analysis.
Respir Care J. 56(8): 1087-1094.
Sim, S. H., Liu, Y., Wang, D., Novem, V., Sivalingam, S. P., Thong, T. W., Ooi, E.
E., Tan, G. 2009. Innate immune responses of pulmonary epithelial cells
to burkholderia pseudomallei infection. Plos One J. 4(10): 7308-7310.
Singh, P. K., Parsek, M. R., Greenberg, E. P., Welsh, M. J., 2002. A component
of innate immunity prevents bacterial biofilm development. Nature J. 471:
552-555.
Steffen, M. J., Ebersole, J. L., 1992. Secretory immune responses to
Mycoplasma Pulmonis. Infect Immunol J. 60: 337-344.
119
Song, H. J. and the Asian HAP Working Group Seoul, Korea. 2008. Treatment
recommendations of Hospital-Acquired Pneumonia in Asian Countries:
first consensus report by The Asian HAP Working Group. The Association
for Professionals in Infection Control and Epidemiology, Inc.
Takesue, Y., Nakajima, K., Ichiki, K., Ishihara, M., Wada, Y., Takahashi, Y.,
Tsuchida, T., Ikeuchi, H. 2010. Impact of a hospital-wide programme of
heterogeneous antibiotic use on the development of antibiotic-resistant
Gram-negative bacteria. Hosp Infect J. 75: 28–32.
Tambunan, T., Soetomenggolo, T. S., Passat, J., Agusman, S. I. 2002. Studi
kohort. di: Sastroasmoro, S., Ismael, S., eds. dasar-dasar metodologi
penelitian klinis, edisi ke 2. Jakarta: Sagung Seto, 128-141.
Tan, J. C., Guzman-Banzon, A., Ayuyao, F., De Guia, T. 2007. Comparison of
CPIS (Clinical Pulmonary Infection Score) and clinical criteria in the
diagnosis of Ventilator-associated Pneumonia in ICU complex patients.
Phil Heart Center J. 13(2): 135-138.
Tejerina, E., Esteban, A., Fernández-Segoviano, P., Frutos-Vivar, F. 2009.
Accuracy of clinical definitions of Ventilator-Associated Pneumonia:
comparison with autopsy findings. Crit Care J. 20:1-7.
The Canadian Critical Care Trials Group. 2006. A Randomized Trial of Diagnostic
Technique for Ventilator-Associated Pneumonia. N Engl Med J. 355: 25;
2619-2630.
Timsit, J-F., Zahar, J-R., Chevret, S. 2011. Attributable mortality of VentilatorAssociated Pneumonia. Cur Opinion in Crit Care J. 17: 464-471.
Torres, A., Ewig. S., Lode, H., Carlet, J. 2008. Defining, treating and preventing
Hospital Acquired Pneumonia: Euripean Perspective. Intensiv Care Med
J. 35: 9-29.
Trouillet, J-L., Chastre, J., Vuagnat, A., Joly-Guillou, M-L., Combaux, D.,
Dombret, M-C., Gibert, C. 1998. Ventilator-associated Pneumonia caused
by potentially Drug-resistant Bacteria. Am Respir Crit Care Med J.
157:531-539.
120
Van Hooser, D. T. 2006. Strategies for the diagnosis of Ventilator-Associated
Pneumonia with expanded description of blind bronchoalveolar lavage
(mini-BAL) methods. Kimberly-Clark Health Care Education. 1-2.
Vardakas, K. Z., Rafailidis, P. I., Konstantelias, A. A., Falagas, M. E. 2012.
Predictors of mortality in patients with infections due to multi-drug
resistant gram negative bacteria: The study, the patient, the bug or the
drug?. Infect J. xx: 1-14.
Vincent, J. L., Bihari, D. J., Suter, P. M. 2009. The prevalence of nosocomial
infection in Intensive Care Units in Europe. Results of the European
Prevalence of Infection In Intensive Care (EPIC) study. JAMA J. 274: 639644.
Violán, J. S., de Castro, F. R., Luna, C. J., Benítez, A. B., Alonso, J. L. M. 1993.
Comparative efficacy of Bronchoalveolar Lavage and Telescoping
Plugged Catheter in the diagnosis of pneumonia in Mechanically
Ventilated Patients.Chest J. 103: 386-390.
Vidaur, L., Sirgo, G., Rodriguez, A. H., Rello, J. 2005. Cinical Aprroach to the
Patient With Suspected Ventilador-Associated Pneumonia. Respir Care J.
50: 956-974.
Wiggins, J., Hill, S. L., Stockley, R. A. 1994. The secretory IgA system of lung
secretions in chronic obstructive bronchitis: comparison of sputum with
secretions obtained during fibreoptic bronchoscopy. Thorax J. 39: 517523.
Wolf, H. M., Fischer, M. B., Puhringer, H. 1994. Human serum IgA downregulates
the release of inflammatory cytokines (Tumor Necrosis Factor-Alpha,
Interleukin-6) In human monocytes.Blood J. 83: 1278-1288.
Wood, G. C., Boucher, B. A., Mueller, E. W., Hanes, S. D., Croce, M. A., Fabian,
T. C. 2005. Evaluation of A Clinical Pathway for Ventilator Associated
Pneumonia: Changes in Bacterial Flora and the Adequacy of Empiric
Antibiotics over a Three-Year Period. Surg Infect J. 203-213.
121
Wright, P. F., Renegar, K. B., Small, P. A, Boykins, L. G. 2004. Murine respiratory
tract of influenza viral infection in the role of IgA versus IgG in the control.
Immunol J. 173: 1978-86.
Wunderink, R. G., Brun-Buisson, C. 2008. Ventilator-Associated Pneumonia:
Lessons Learned from Clinical Trials. Crit Care J. 23: 2-4.
Zaccard, C. R., Schell, R. F., Spiegel, C. A. 2009. Efficacy of bilateral
Bronchoalveolar Lavage for Diagnosis of Ventilator-Associated
Pneumonia. Clin Microbiol J. 47(9): 2918-2924.
BAB 7
DAFTAR PUSTAKA
Afessa, B., Hubmayr, R. D., Vetter, E. A., Keegan, M. T., Swanson, K. L.,
Baddour,L.M., Cockerill III,F.R., Peters,S.G. 2006. Bronchoscopy in
Ventilator-Associated Pneumonia: agreement of calibrated loop and serial
dilution. Am Respir Crit Care Med J. 173: pp 1229-1232.
Aghamohammadi, A., Moin, M., Farhoudi, A.,Rezaei, N., Pourpak, Z., Movahedi,
M., Gharagozlou, M., Nabavi, M., Shahrokhi, A. 2004. Efficacy of
intravenous immunoglobulin on the prevention of pneumonia in patients
with agammaglobulinemia. FEMS Immunol Med Microbiol J. 40:113-118.
Aguald-Ohman, C., 2007. Colonization, infection and dissemination in intensive
care patients. Department Intensive Care and clinical bacteriology,
Karolinska Institutet, Stochkhom, Sweden. 1st ed.
Ahl, J., Tham, J., Walder, M., Melander, E., Odenholt, I. 2010. Bacterial aetiology
in Ventilator-Associated Pneumonia at a Swedish University Hospital.
Scandinavian Infect Dis J. 42: 469-474.
American Thoracic Society Documents. 2005. Guidelines for the management of
adult with Hospital-Acquired, Ventilator-Associated and HealthcareAssociated Pneumonia. Am Respir Crit Care Med J. 171: 388-416.
Apostolopoulou, E., Charcharidou, M., Karga, A., Kaliakmanis. 2003. The
relationship of scoring systems and mortality in the intensive care unit.
Icus Nurs Web J.6: 1-8.
Augustyn, B. 2007. Ventilator–Associated Pneumonia: Risk Factors and
Prevention. Am Crit Care J. 27: 32-39.
Ballow, M. 2008. Immunoglobulin therapy methods of delivery. Allergy Clin
Immunol J. 122:1038-1039.
Bals, R., Hiemstra, P. S. 2004. Innate immunity in the lung : how epithelial cells
figh against respiratory pathogens. Eur Respir J. 23: 327-333.
105
106
Barreiro, B., Dorca, J., Manresa, F., Catalá, I., Esteban, L., Verdaguer, R.,
Gudiol, F. 1996. Protected Bronchoalveolar Lavage in the diagnosis of
Ventilator-Associated Pneumonia. Eur Respir J. 9: 1500-1507.
Baughman, R. P. 2007. Technical aspects of Bronchoalveolar Lavage:
Recommendations for a Standard Procedure. Semin Respir Crit Care
Med J. 28: 475-85.
Befus, A. D., Mowat, C., Gilchrist, C., Jing, H., Salomon, S., Baterman, A. 1999.
Neutrophil defences in induce histamine secreton from mast cells
mechanisms of action. Immunol J. 163: 947-953.
Bitonti, A. J., Dumount, J. A. 2006. Pulmonary administrations of therapeutic
proteins using an immunoglobulin transport pathway. Adv Drug Deliv Rev
J. 58:1106-1118.
Brandtzaeg, P. 1994. Human secretory immunoglobulin M. Immunol J. 29: 559565.
Budiarto, E. 2002. Biostatistika untuk kedokteran dan kesehatan masyarakat.
Jakarta: EGC.79-84
Boyton, R. J., Openshaw, P. J. 2002. Pulmonary defences to acute respiratory
infection. Br Med Bull J. 61:1-12.
Casetta, M., François, B., Antoun, S., Leclercq, B., Tancrède, C., Françoise, D.,
Nitenberg, G. 1999. Diagnosis of nosocomial pneumonia in cancer
patients undergoing mechanical ventilation a prospective comparison of
the plugged telescoping catheter with the protected specimen brush.
Chest J. 115: 1641-1645.
Chastre, J., Fagon, J. Y. 2002. Ventilator-Associated Pneumonia. Am Respir Crit
Care Med J. 165: 867-903.
Chawla, R. 2008. Epidemiology, etiology, and diagnosis of Hospital-Acquired
Pneumonia and Ventilator-Associated Pneumonia In Asian Countries . Am
Infect Control J. 36: 93-100.
107
Chung, D. R., Song, J-H., Kim, S. H., Thamlikitkul, V., Huang, S-G., Wang, H.,
So, T. M-k., Yasin, R. M. D., Hsueh, P-R., Carlos, C. C., Hsu, L. Y.,
Buntaran, L., Lalitha, M. K., Kim, M. J., Choi, J. Y., Kim, S. I., Ko, K. S.,
Kang, C-I., Peck, K. R. 2011. High prevalence of Multidrug-Resistant
Nonfermenters in Hospital-Acquired Pneumonia in Asia. Am Respir, Crit
Care Med J. 184 (12): 1409-17.
Clec’h, C., Jauréguy, F., Hamza, L., Karoubi, P., Fosse, J-P., Hamdi, A.,
Vincent, F., Gonzalez, F., Cohen, Y. 2006. Agreement between
quantitative cultures of postintubation tracheal aspiration and plugged
telescoping catheter, protected specimen brush, or BAL for the diagnosis
of nosocomial pneumonia. Chest J. 130: 956-961.
Cohen, A. L., Calfee, D., Fridkin, S. K., Huang, S. S., Jernigan, J. A., Lautenbach,
E., Oriola, S., Ramsey, K. M., Salgado, C. D., Weinstein, R. A. 2008.
Recommendations for metrics for Multidrug-Resistant Organisms in
healthcare settings: SHEA/HICPAC position paper. Infect Contr and Hosp
Epid J. 29: 901-13.
Cook, D. J., Walter, S.D ., Cook, R. J. 1998. Incidence of and Risk Factors for
Ventilator-Associated Pneumonia In Critically Ill Patients.
Ann Intern
Med J. 129:433-440.
Cordeiro, C. R., Cemlyn-Jones, J. 2008. Bronchoalveolar Lavage – Do We Need
It?. Professor and Resident Pulmonary Specialist Registrar, Department
of Pulmonology and Allergology, Coimbra University Hospital. Eur Respir
Dis J. 33-35.
Craven, D. E. 2006. 2005 Idsa/Ats Hospital-Acquired Pneumonia Guidelines: new
principles for improving management. Adv Stud Med J. 6(6C): S541S548.
Dahlan, M. D. 2013. Statistik untuk kedokteran dan kesehatan: deskriptif, bivariat,
dan multivariat, dilengkapi dengan menggunakan SPSS, edisi 5, cetakan
III. Jakarta: Penerbit Salemba Medika.
108
Danielle, R. P. 1999. Imunology sectretion in the airway. Annu Rev Physiol J. 52 :
177-195.
Dave, S., Carmicle, S., Hammerschmidt, S., Pangburn, M. K., McDaniel, L. S.
2004. Dual Roles of PspC, a Surface Protein of Streptococcus
pneumoniae, in Binding Human Secretory IgA and Factor H. Immunol J.
173: 471-477.
Delevaux, C., Roupie,Blot, E. F., Brochard, L., Lemaire, F., Brun-Buisson, C.
1997. Lower respiratory tract colonization and infection during severe
Acute Respiratory Distress Syndrome incidence and diagnosis. Am Respir
Crit Care Med J. 156:1092-1098.
Dennesen, P. J. W., Van Der Ven, A. J. A. M., Kessels, A. G. H., Ramsay, G.,
Bonten, M. J. M. 2001. Resolution of infectious parameters after
antimicrobial therapy in patients with Ventilator-associated Pneumonia.
Am Respir Crit Care Med J. 1371-1375.
Deša, K., Šustiæ, A., Krstuloviæ, B., Goluboviæ, V. 2005. Evaluation of single
intensive care unit performance by Simplified Acute Physiology Score II
system. Croat Med J. 46(6): 964-969.
Dey, A., Bairy, I. 2007. Incidence of Multidrug-Resistant Organisms causing
Ventilator-Associated Pneumonia in a tertiary care hospital: a nine
months' prospective study. Ann Thorac Med J. 2(2): 52-57.
Diebel, L. N., Liberati, D. M., Alfred, M. S., Baylor, E., Brown, W. J., Devlin, J.
2004. Immunoglobulin A protease is a virulence factor for gram-negative
pneumonia. Surg J .136: 937-943.
Diebel, L. N., Liberati, D. M., Baylor, A. E., Brown, W. J., Devlin, J. 2004.
Immunoglobulin A protease is a virulence factor for gram-negative
pneumonia. Surg J. 937-943.
Diebel, L. N., Liberati, D. M., White, M. T., Diglio, C. A., Brown, W. J. 2006.
A comparative study of secretory immunoglobulin A and immunoglobulin
G in host defense in an in vitro pneumonia model. Am Surg J. 191: 386390.
109
Diebel, L. N., Liberati, D., Amin, P. B., Diglio, C. A. 2009. Cleavage of sIgA by
gram negative respiratory pathogens enhance neutrophil inflammatory
potential. Trauma J. 66: 5;1336-1342.
Diebel, L. N., Liberati, D. M., Diglio, C. A. 2009. The relative roles of bacteria and
host inflammatory cells in sIgA degradation. Trauma J. 66:6;1556-1563.
Duflo,F., Debon,R., Monneret,G., Bienvenu,J., Chassard,D., Allaouchiche,B.,
2002. Diagnostic and Prognostic Value in Ventilator-associated
Pneumonia. Anest J. 96: 74-79.
Elatrous, S., Boukef , R., Besbes, L. O., Marghli, S., Nooman, S., Nouira, S.,
Abroug, F. 2004. Diagnosis of Ventilator-Associated Pneumonia:
agreement between quantitative cultures of endotracheal aspiration and
plugged telescoping catheter. Intensiv Care Med J. 30: 853-858.
Elgert, K. D. 2009. Immunology, Understanding The Immun System. 2nd, Hoboken
Inc. New Jersey. 9-32
El-Herte,R.S., Kanj,S.S., Matar,S.G.M., Araj,G.F. 2012. The
Threat of
Carbapenem-Resistant Enterobacteriaceae In Lebanon: An update on
the regional and local epidemiology. Infect and Pub Health J. 5: 233243.
Erbay, R. H., Yalcin, A. N., Zencir, M., Serin, S., Atalay, H. 2004. Research article
costs and risk factors for Ventilator-Associated Pneumonia In a Turkish
University Hospital's Intensive Care Unit: A case-control study. BMC
Pulmo Med J. 4:3;1-7.
Erle, D. J., Zhen, G. 2006. Microbiological Diagnosis of Ventilator-associated
Pneumonia: Using the Data to Optimize Clinical Outcomes. Am J Respir
Crit Care Med J. 173: 1182-1184.
Fagon, J-Y., Chastre, J. 2003. Diagnosis and treatment of nosocomial pneumonia
in ALI/ARDS patients. Eur Respir J. 22: Suppl. 42, 77s-83s.
110
Fagon, J-Y., Chastre, J., Rouby, J-J. 2007. Is Bronchoalveolar Lavage with
quantitative cultures a useful tool for diagnosing Ventilator-Associated
Pneumonia?. Crit Care J. 11: 123-125.
Fartoukh, M., Maître, B., Honore, S., Cerf, C., Zahar, J-R., Brun-Buisson, C.
2003. Diagnosing pneumonia during mechanical ventilation: The Clinical
Pulmonary Infection Score revisited. Am Respir Crit Care Med J. 168:
173-179.
Ferrer, M., Liapikou, A., Martinez, J. A., Mensa, J., Valencia, M., Torres, A.,
Esperatti, M., Theessen, A. 2010. Validation of the American Thoracic
Society–Infectious Diseases Society of America Guidelines for HospitalAcquired Pneumonia in the Intensive Care Unit. Clin Infect Dis J. 50: 945952.
File, T. M. 2010. Recommendations for treatment of Hospital Acquired and
Ventilator-Associated Pneumonia: review of recent International
guidelines. Infect Dis Soc Am J. S42-S47.
Furst, D, E. 2008. serum immunoglobulins and risk of infection: how low can you
go?. Semin Arth Rheum J. 39:18-29.
George, D. L. 1995. Epidemiology of Nosocomial Pneumonia in Intensive Care
Unit Patients. Clin Chest Med J. 16:1; 29-44.
Giantsou, E., Liratzopoulos, N., Efraimidou, E., Panopoulou, M., Alepopoulou, M.
E., Kartali-Ktenidou, S., Minopoulos, G. I., Zakynthinos, S., Manolas, K. I.
2005. Both Early-onset and Late-onset Ventilator-Associated Pneumonia
Are Caused Mainly by Potentially Multiresistant Bacteria. Intensiv Care
Med J. 31:1488-1494.
Grigoriu, B., Jacobs, F., Beuzen, F. 2005. Bronchoalveolar lavage cytological
alveolar damage in patients with severe pneumonia. BMC Pulmo Med J.
6: 10-16.
Gorman, S. K., Stewart, L. M., Slavix, R. S., Lemos, J., Chittock, D. 2009.
Identifying missed opportunities to curtail antimicrobial therapy for
111
presumed Ventilator-Associated Pneumonia using the Clinical Pulmonary
Infection Score. Can Hosp Pharm J. 62: 3; 217-225.
Gottesman, S. R. S., Strober, W. 2009. Immunology, Clinical Case Studies and
Diseases Pathophysiology. Hoboken Inc, New Jersey.
Guler, E., Kahveci, F., Akalin, H., Sinirtas, M., Bayram, S., Ozcan, B. 2012.
Evaluation of A Clinical Pulmonary Infection Score In The Diagnosis of
Ventilator-Associated Pneumonia. Signa Vitae J. 7(1): 32-37.
Hajishengallis, G., Nikolova, E., Russell, M. W. 1992. Inhibition of streptococcus
mutans adherence to saliva-coated hydroxyapatite by human secretory
immunoglobulin A (S-IgA) antibodies to cell surface protein antigen 1/11:
reversal by iga1 protease cleavage. Infect Immun J. 60:2; 5057-5064.
Halbertsma, F. J. J., Vaneker, M., Scheffer, G. C., Van Der Hoeven, J.G. 2005.
Cytokines and biotrauma in Ventilator Induced Lung Injury: a critical
review of the literature. Med J. 63;10:382-392.
Hamilton,L.A., Wood,G.C., Magnotti,L.J., Croce,M.A., Martin,J.B., Swanson,J.M.,
Boucher,B.A., Fabian,T.C. 2012.
Treatment of Methicillin-Resistant
Staphylococcus aureus Ventilator-Associated Pneumonia With HighDose Vancomycin or Linezolid. Trauma Acute Care Surg J. 72(6):
1478-1483.
Harde, Y., Rao, S. M., Sahoo, J., Bharuka, A., Swetha, B., Saritha, P. 2013.
Detection Of Ventilator Associated Pneumonia, using Clinical Pulmonary
Infection Score (CPIS) In critically ill neurological patients. Anest Clin
Scien J. 2: 20-22.
Haslam, P. L., Baugham, R. P. 1999. Report of ERS task force: guidelines for
measurement of a cellular components and standardization of BAL. Eur
Respir J.14: 245-248.
Horan, T. C., Andrus, D. M. A. 2008. CDC/NHSN Surveillance definition of Health
Care–Associated Infection and criteria for specific types of infections in
the acute care setting. Am Infect Contr J. 36: 309-332.
112
Huang, K-T., Tseng, C- C., Fang, W-F., Lin, M-C. 2010. An Early predictor of
The outcome of Patients with Ventilator-associated Pneumonia. Chang
Gung Med J. 33: 274-282.
Hunter, J. D. 2006. Ventilator- Associated Pneumonia. Postgrad Med J. 82:172178.
Ibrahim,E.H., Ward,S., Sherman,G., Kollef,M.H. 2000. A Comparative Analysis
of Patients With Early-Onset vs Late-Onset Nosocomial Pneumonia in
the ICU Setting. Chest J. 117:1434-1442.
Inglis, T. J., Millar, M. R., Jones, G., Robinson, D. 1989. Tracheal tube biofilm as
a source of bacterial colonization of the lung. Clin Microbiol J. 2014-2018.
Ioanas, M., Ferrer, R., Angrill, J., Ferrer, M., Torres, A. 2001. Microbial
investigation in Ventilator-associated Pneumonia. Eur Respir J. 17: 791801.
Jiménez, P., Saldías, F., Meneses, M., Silva, M. E., Wison, M. G., Otth, L. 1993.
Diagnostic fiberoptic bronchoscopy in patients with Community-acquired
Pneumonia: Comparison Between Bronchoalveoar Lavage and
telescoping plugged catheter cultures. Chest J. 103: 1023-1027.
Jeon,E.J., Jung,J.W., Choi,J.C., Shin,J.W., Park,I.W., Choi,B.W., Park,A.J.,
Kim,J.Y. 2010. The Value of Procalcitonin and the SAPS II and
APACHE III Scores in the Differentiation of Infectious and Noninfectious Fever in the ICU: A Prospective, Cohort Study. Korean Med
Sci J. 25(11): 1633-1637.
Jones, R. N. 2010. Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia
and Ventilator-Associated Bacterial Pneumonia. Clin Microbiol Rev J. 51:
S81-S87.
Joseph, N. M., Sistla, S., Dutta, T. K., Badhe, A. S., Parija, S. C. 2010. VentilatorAssociated Pneumonia: Role Of Colonizers And Value Of Routine
Endotracheal Aspirate Cultures. Inter Infect Dis J. 14: e723-e729.
113
Kayacan, O., Beder, S., Karnak, D. 2003. Cellular profile of Bronchoalveolar
Lavage fluid in Turkish Miners. Postgrad Med J. 79: 527–530.
Klompas, M., Kulldorff, M., Platt, R. 2008. Risk of misleading VentilatorAssociated Pneumonia rates with use of standard clinical and
microbiological criteria. Clin Infect Dis J. 46: 1443–6.
Klompas, M., Yokoe, D. S. 2009. Automated Surveillance of Health Care–
Associated Infections. CID Healthcare Epid J. 48: 1268-1275.
Koenig, S. M., Truwit, J. D. 2006. Ventilator-Associated Pneumonia: Diagnosis,
Treatment, and Prevention. Clin Microbiol Rev J. 637-657.
Koerner, R. J. 2004. Contribution of endotracheal tubes to the pathogenesis of
Ventilator-Associated Pneumonia. Hosp Infect J. 35: 83-89.
Kollef, M. H. 2006. Microbiological diagnosis of Ventilator-Associated Pneumonia.
Am Respir Crit Care Med J. 173: 2006-2007.
Lamm, M. E. 2006. How epithelial transport of IgA antibodies relates to host
defense. Am Phisiol Gastrointest J. 274: 614-617.
Laursen, A. L., Jensen, B. N., Andersen, P. L. 1994. Local antibodies against
pneumocystis carinii in bronchoalveolar lavage Fluid. Eur Respir J. 7: 679685.
Le-Gall, J-R., Neumann, A., Hemery, F., Bleriot, J. P., Fulgencio, J. P., Garrigues,
B., Gouzes, C., Lepage, E., Moine, P., Villers, D. 2005. Mortality
prodiction using SAPS II: an update for french intensive care unit. Crit
Care J. 9: 645-652.
Lee, W. L., Downey, G. P. 2001. Neutrophil activation and Acute Lung Injury. Cur
Opinion in Crit Care J. 7: 1-7.
Leo, A., Galindo-Galindo, J., Folch, E., Guerrero, A., Arroliga, A. C., Bosques, F.,
Mercado, R. 2008. Comparison Of Bronchoscopic Bronchoalveolar
Lavage Vs Blind Lavage with a modified nasogastric tube in the etiologic
diagnosis of Ventilator-Associated Pneumonia. Med Intensiv J. 32(3): 115120.
114
Levin, A. S., Oliveira, M. S. 2008. The challenge of Multidrug Resistance: the
treatment of gram-negative rod infections. Shock J. 30: S1: 30-33.
Linssen, C. F.M. 2007. Diagnostic Value of Bronchoalveolar Lavage in Infectious
Disorders. Datawyse Universitaire Pers Maastracht.1st ed
Liu,K-S., Wang,Y-T., Lai,Y-C., Yu,S-F., Huang,S-J., Lu,H-J.M-C., Hsueh,P-R.
2011. Antimicrobial resistance of bacterial isolates from respiratory care
wards in Taiwan: a horizontal surveillance study comparison of the
characteristics of nosocomial infection and antimicrobial-resistant bacteria
in adult Intensive Care Units and two respiratory care facilities for
mechanically ventilated patients at a tertiary care centre in Taiwan. Intern
Antimicrobial Agents J. 37: 10-5.
Luna, C. M., Aruj, P., Niederman, G. J., Violi, D., Prignoni, A., Rίos, F., Baquero,
S., Gando, S. 2006. Appropriateness and Delay to Initiate Therapy in
Ventilator-Associated Pneumonia. Eur Respir J. 27: 158-64.
Lusuardi, M., Capelli, A., Stefano, A. F., Donner, C. F. 2002. Lung mucosal
immunity: immunoglobulin - A Revised. Eur Respir J. 19: 785-786.
Mai, M-H., Tsai, H-C., Lee, Z. S-J., Wang, Y-H., Chen, Y-S., Wann, S-R., Liu, YC. 2007. Multidrug-Resistant Acinetobacter baumannii In VentilatorAssociated Pneumonia at a medical center in Southern Taiwan. Microbiol
Immunol Infect J. 40: 401-405.
Mara, A. R., Cal, R. G. R., Silva, C. V., Caserta, R. A., Paes, Â. T., Moura, D. F.,
Santos, F. P., Edmond, M. B., Durão, M. S. 2009. Succesful prevention of
Ventilator-associated Pneumonia in an intensive care setting. Am Infect J.
37: 619-625.
Martin, T. R., Frevert, C. W. 2005. Innate immunity in the lungs. Proc Am Thorac
Sov J. 2: 403-411.
McGowan Jr, J. E. 2006. Resistance in Nonfermenting Gram-Negative Bacteria:
Multidrug Resistance to The Maximum. Am Infect Control J. 34: S29-S37.
Mayer, L., 2003. Mucosal immunity. Ped J. 111: 1595-1600.
115
Medford, A. R. L., Husain, S. A., Turki, H. M., Millar, A. B., 2009. Diagnosis of
Ventilator-Associated Pneumonia. Crit Care J. 24: 473.1-6.
Medzhitov, R. 2008. Origin and physiological roles of inflammation. Nature J.
454: 428-436.
Mestecky, J. 2005. Mucosal immunology 3rd ed. Academic press, San Diego.
72-79.
Meyer, K. C., Raghu, G., Baughman, R. P., Brown, K. K., Costabel, U., Bois, R.
M., Drent, M., Haslam, P. L., Kim, D. S., Nagai, S., Rottoli, P., Saltini, C.,
Selman, M., Strange, C., Wood, B., and the American Thoracic Society
Committee on BAL in Interstitial Lung Disease. 2012. Guideline: The
clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung
disease. Am Respir Crit Care Med J. 185: 9; 1004-1014.
Meyer, K. C. 2012. The value of Bronchoalveolar Lavage In the diagnosis and
management of Interstitial Lung Disease. Chest J. 271-293.
Mietto, C., Pinciroli, R., Patel, N., Berra, L. 2013. Ventilator Associated
Pneumonia: evolving definitions and preventive strategies. Respir Care
J.13:256-9.
Milbrandt, E. B., Ishizaka, A., Angus, D. C. 2006. Update in Critical Care 2005.
Am Respir Crit Care Med J. 173: 833-841.
Mimoz, O., Karim, J., Mazoit, J. X., Edouard, A., Leprince, S., Nordmann, P.
2000. Gram Staining of Protected Pulmonary, Specimens in The Early
Diagnosis of Ventilator-Associated Pneumonia. Br Anaesth J. 85: 735739.
Morrison, D., Strieter, R. M., Donnelly, S. C., Burdick, M. D. 1998. Neutrophil
Chemokines in Bronchoalveolar Lavage Fluid and Leukocyte-Conditioned
Medium From Nonsmokers and Smokers.Eur Respire J. 998: 12; 10671072.
Müller, B., Harbarth, S., Stolz, D., Bingisser, R., Mueller, C., Leuppi, J.,
Nusbaumer, C., Tamm, M., Christ-Crain, M. 2007. Diagnostic and
116
prognostic accuracy of clinical and laboratory parameters in communityacquired pneumonia. BMC Infect Dis J. 7:10-12.
Munro, C. L., Grap, M. J. 2004. Oral health and care in the intensive care unit:
state of the science. Am Crit Care J.13: 25-34.
Muòz, A. R., 2005. Mucosal immunity in the respiratory tract: the role of IgA in
protection against intracellular pathogens. Doctoral thesis from the
department of immunology, The Wenner-Gren Institute, Stockholm
University. Stockholm.
Nicasio, A. M., Eagye, K. J., Nicolau, D. P., Shore, E., Palter, M., Pepe, J., Kuti,
J. L. 2010. Pharmacodynamic-based clinical pathway for empiric antibiotic
choice in patients with Ventilator-associated Pneumonia. Crit Care J. 25:
69-77.
Niederman, M. S. 2005. The Clinical Diagnosis of Ventilator-Associated
Pneumonia. Respir Care J. 50(6): 788-796.
Noble, P. W., Jiang, D. 2006. Matrix regulation of lung injury, inflammation and
repair. the role of innate immunity.Proc Am Thorac Soc J. 3: 401-404.
Ntoumenopoulos,G., Presneill,J.J., McElholum,M., Cade,J.F. 2002.Chest
physiotherapy for the prevention of Ventilator-Associated Pneumonia.
Intensiv Care Med J. 28: 850-856.
Oeckler, R. A., Hubmayr, R. D. 2007. Ventilator-associated Lung Injury: a search
for better therapeutic targets. Eur Respir J. 30: 1216-1226.
Parks, N. A., Magnotti, L. J., Weinberg, J. A., Zarzaur, B. L., Schroeppel, T. J.,
Swanson, J. M., Fabian, T. C., Croce, M. A. 2012. Use of The Clinical
Pulmonary Infection Score To Guide Therapy For Ventilator-Associated
Pneumonia Risks Antibiotic Over exposure In Patients With Trauma.
Trauma Acute Care Surg J. 52-59.
Prakash, P., Krishna, K., Bhatia, D. 2006. Usefulness of SAPS II Scoring system
as an early predictor of outcome in ICU patients. JIACM J.7(3): 202-205.
117
Pugin, J., Auckenthaler, R., Mill, N., Janssens, J-P., Lew, P. D., Suter, P. M.
1991. Diagnosis of Ventilator-associated Pneumonia by Bacteriologic:
Analysis of Bronchoscopic and Nonbronchoscopic "Blind"
Bronchoalveolar Lavage Fluid. Am Rev Respir Dis J. 143: 1121-1129.
Ramirez, P., Valencia, M., Torres, A. 2007. Bronchoalveolar Lavage to diagnose
respiratory infections. Semin Respir Crit Care Med J. 28: 525-533.
Ranes, J. L., Gordon, S., Arroliga, A. C. 2005. Hospital-Acquired, Health Care–
Associated, and Ventilator-Associated Pneumonia. Cleveland Clinic.
1.1.1.1 Rasmin, M., 2012. Bronchoalveolar Lavage pada interstitial lung
disease, Departemen Pulmonologi dan Ilmu Kedokteran Respirasi FKUI –
SMF Paru RSUP Persahabatan, Jakarta
Rello, J., Gallego, M., Mariscal, D., Soñora, R., Valles, J. 1997. The value of
routine microbial investigation in Ventilator-Associated Pneumonia. Am
Respir Crit Care Med J. 156:196-200.
Rello, J., Sa-Borges, M., Correa, H., Leal, S-R., Baraibar, J. 1999. Variations in
etiology of Ventilator-associated Pneumonia across four treatment sites:
implications for antimicrobial prescribing practices. Am Respir Crit Care
Med J. 160: 608-613.
Rea-Neto, A., Youssef, N. C. M., Tuche, F., Brunkhorst, F., Raniere, V. M.,
Reinhart, K. 2008. Diagnosis of Ventilator-Associated Pneumonia: a
systemic review of the literature. Crit Care J. 12: 56-70.
Renegar, K. B., Small, P. A., Boykins, J. L. G., Wright, P. F. 2004. Role of IgA
versus IgG in the control of influenza viral infection in the murine
respiratory tract. Immunol J.173: 1978-1986.
Reutershan, J., Ley, K., 2004. Bench-to-bedside review: Acute Respiratory
Distress Syndrome-how neutrophils migrate into the lung. Crit Care J. 8:
453-461.
Roon, A. H. R., Bonten, M. J. M., Gaillard, A. C. 1998. Prediction of clinical
severity and outcome of Ventilator-associated Pneumonia, comparison of
118
Simplified Acute Physiology Score with systemic inflammatory mediators.
Am Respir Crit Care Med J.158: 1026-1031.
Rotstein, C., Evans, G., Born, A., Grossman, A., Light, R. B., Magder, S.,
Taggart, B., Weiss, K., Zhanel, G. G. 2008. Ammi Canada Guidelines:
clinical practice guidelines for Hospital-Acquired Pneumonia and
Ventilator -Associated Pneumonia in adults. Can Infect Dis Med Microbiol
J. 19: 19-53
Safdar, N., Crnich, C. J., Maki, J. G., 2005. The Pathogenesis of VentilatorAssociated Pneumonia: Its Relevance to Developing Effective Strategies
for Prevention. Respir Care J. 50: 6; 725-742.
Santoso, Singgih. 2012. Aplikasi SPSS pada statistik multivariat. Jakarta: PT Elex
Media Komputindo. 11-85.
Satcher, D. 1997. Centers for disease control and prevention. Guidelines for
prevention of nosocomial pneumonia. MMWR J. 46: 1-67.
Schmekel, B., Venge, P., Hörnblad, Y., Norlund, A. L., Hvatum, M. 1995. Kinetic
retrieval of eosinophil cationic protein, hyaluronan, secretory IgA, albumin,
and urea during BAL in healthy subjects. Chest J. 108: 62-67.
Shan, J., Chen, H-L., Zhu, J-H. 2011. Diagnostic accuracy of Clinical Pulmonary
Infection Score for Ventilator-Associated Pneumonia: a meta-analysis.
Respir Care J. 56(8): 1087-1094.
Sim, S. H., Liu, Y., Wang, D., Novem, V., Sivalingam, S. P., Thong, T. W., Ooi, E.
E., Tan, G. 2009. Innate immune responses of pulmonary epithelial cells
to burkholderia pseudomallei infection. Plos One J. 4(10): 7308-7310.
Singh, P. K., Parsek, M. R., Greenberg, E. P., Welsh, M. J., 2002. A component
of innate immunity prevents bacterial biofilm development. Nature J. 471:
552-555.
Steffen, M. J., Ebersole, J. L., 1992. Secretory immune responses to
Mycoplasma Pulmonis. Infect Immunol J. 60: 337-344.
119
Song, H. J. and the Asian HAP Working Group Seoul, Korea. 2008. Treatment
recommendations of Hospital-Acquired Pneumonia in Asian Countries:
first consensus report by The Asian HAP Working Group. The Association
for Professionals in Infection Control and Epidemiology, Inc.
Takesue, Y., Nakajima, K., Ichiki, K., Ishihara, M., Wada, Y., Takahashi, Y.,
Tsuchida, T., Ikeuchi, H. 2010. Impact of a hospital-wide programme of
heterogeneous antibiotic use on the development of antibiotic-resistant
Gram-negative bacteria. Hosp Infect J. 75: 28–32.
Tambunan, T., Soetomenggolo, T. S., Passat, J., Agusman, S. I. 2002. Studi
kohort. di: Sastroasmoro, S., Ismael, S., eds. dasar-dasar metodologi
penelitian klinis, edisi ke 2. Jakarta: Sagung Seto, 128-141.
Tan, J. C., Guzman-Banzon, A., Ayuyao, F., De Guia, T. 2007. Comparison of
CPIS (Clinical Pulmonary Infection Score) and clinical criteria in the
diagnosis of Ventilator-associated Pneumonia in ICU complex patients.
Phil Heart Center J. 13(2): 135-138.
Tejerina, E., Esteban, A., Fernández-Segoviano, P., Frutos-Vivar, F. 2009.
Accuracy of clinical definitions of Ventilator-Associated Pneumonia:
comparison with autopsy findings. Crit Care J. 20:1-7.
The Canadian Critical Care Trials Group. 2006. A Randomized Trial of Diagnostic
Technique for Ventilator-Associated Pneumonia. N Engl Med J. 355: 25;
2619-2630.
Timsit, J-F., Zahar, J-R., Chevret, S. 2011. Attributable mortality of VentilatorAssociated Pneumonia. Cur Opinion in Crit Care J. 17: 464-471.
Torres, A., Ewig. S., Lode, H., Carlet, J. 2008. Defining, treating and preventing
Hospital Acquired Pneumonia: Euripean Perspective. Intensiv Care Med
J. 35: 9-29.
Trouillet, J-L., Chastre, J., Vuagnat, A., Joly-Guillou, M-L., Combaux, D.,
Dombret, M-C., Gibert, C. 1998. Ventilator-associated Pneumonia caused
by potentially Drug-resistant Bacteria. Am Respir Crit Care Med J.
157:531-539.
120
Van Hooser, D. T. 2006. Strategies for the diagnosis of Ventilator-Associated
Pneumonia with expanded description of blind bronchoalveolar lavage
(mini-BAL) methods. Kimberly-Clark Health Care Education. 1-2.
Vardakas, K. Z., Rafailidis, P. I., Konstantelias, A. A., Falagas, M. E. 2012.
Predictors of mortality in patients with infections due to multi-drug
resistant gram negative bacteria: The study, the patient, the bug or the
drug?. Infect J. xx: 1-14.
Vincent, J. L., Bihari, D. J., Suter, P. M. 2009. The prevalence of nosocomial
infection in Intensive Care Units in Europe. Results of the European
Prevalence of Infection In Intensive Care (EPIC) study. JAMA J. 274: 639644.
Violán, J. S., de Castro, F. R., Luna, C. J., Benítez, A. B., Alonso, J. L. M. 1993.
Comparative efficacy of Bronchoalveolar Lavage and Telescoping
Plugged Catheter in the diagnosis of pneumonia in Mechanically
Ventilated Patients.Chest J. 103: 386-390.
Vidaur, L., Sirgo, G., Rodriguez, A. H., Rello, J. 2005. Cinical Aprroach to the
Patient With Suspected Ventilador-Associated Pneumonia. Respir Care J.
50: 956-974.
Wiggins, J., Hill, S. L., Stockley, R. A. 1994. The secretory IgA system of lung
secretions in chronic obstructive bronchitis: comparison of sputum with
secretions obtained during fibreoptic bronchoscopy. Thorax J. 39: 517523.
Wolf, H. M., Fischer, M. B., Puhringer, H. 1994. Human serum IgA downregulates
the release of inflammatory cytokines (Tumor Necrosis Factor-Alpha,
Interleukin-6) In human monocytes.Blood J. 83: 1278-1288.
Wood, G. C., Boucher, B. A., Mueller, E. W., Hanes, S. D., Croce, M. A., Fabian,
T. C. 2005. Evaluation of A Clinical Pathway for Ventilator Associated
Pneumonia: Changes in Bacterial Flora and the Adequacy of Empiric
Antibiotics over a Three-Year Period. Surg Infect J. 203-213.
121
Wright, P. F., Renegar, K. B., Small, P. A, Boykins, L. G. 2004. Murine respiratory
tract of influenza viral infection in the role of IgA versus IgG in the control.
Immunol J. 173: 1978-86.
Wunderink, R. G., Brun-Buisson, C. 2008. Ventilator-Associated Pneumonia:
Lessons Learned from Clinical Trials. Crit Care J. 23: 2-4.
Zaccard, C. R., Schell, R. F., Spiegel, C. A. 2009. Efficacy of bilateral
Bronchoalveolar Lavage for Diagnosis of Ventilator-Associated
Pneumonia. Clin Microbiol J. 47(9): 2918-2924.